Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

NCT: NCT07340073 · NOT_YET_RECRUITING

NCT IDNCT07340073
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2031-07-01

Brief Summary

Deep brain stimulation (DBS) is a surgical implant procedure for the treatment of Parkinson's Disease (PD) utilizing medical devices approved by the FDA. A novel approach to current DBS approaches is called "Coordinated Reset" DBS (CR-DBS) which uses different patterns of stimulation at lower currents and can address the limitations of traditional DBS (T-DBS) that uses continuous high amplitude and high frequency stimulation. This study will evaluate the safety and short-term efficacy of CR-DBS in PD. The results from this study will significantly advance the development of CR-DBS for the treatment of PD. Findings in this study will also provide the rationale for further development of this novel DBS approach for other neurological and psychiatric disorders.

Frequently Asked Questions

What is Coordinated Reset Deep Brain Stimulation for Parkinson's Disease?

Coordinated Reset Deep Brain Stimulation for Parkinson's Disease is a clinical trial registered under NCT07340073. Current status: NOT_YET_RECRUITING.

What is the status of NCT07340073?

The current status of NCT07340073 (Coordinated Reset Deep Brain Stimulation for Parkinson's Disease) is: NOT_YET_RECRUITING.

When did Coordinated Reset Deep Brain Stimulation for Parkinson's Disease start?

Coordinated Reset Deep Brain Stimulation for Parkinson's Disease started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.